|
1
|
Parkin DM: International variation.
Oncogene. 23:6329–6340. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray FI and Devesa SS: Cancer
burden in the year 2000. The global picture. Eur J Cancer. 37(Suppl
8): S4–S66. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stadtländer CT and Waterbor JW: Molecular
epidemiology, pathogenesis and prevention of gastric cancer.
Carcinogenesis. 20:2195–2208. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Forman D and Burley VJ: Gastric cancer:
Global pattern of the disease and an overview of environmental risk
factors. Best Pract Res Clin Gastroenterol. 20:633–649. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xia J, Guo X, Yan J and Deng K: The role
of miR-148a in gastric cancer. J Cancer Res Clin Oncol.
140:1451–1456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicateds
that thousands of human genes are microRNA targets. Cell.
120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng Y, Yi R and Cullen BR: MicroRNAs and
small interfering RNAs can inhibit mRNA expression by similar
mechanisms. Proc Natl Acad Sci USA. 100:9779–9784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng Y, Wagner EJ and Cullen BR: Both
natural and designed micro RNAs can inhibit the expression of
cognate mRNAs when expressed in human cells. Mol Cell. 9:1327–1333.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chin LJ, Ratner E, Leng S, Zhai R, Nallur
S, Babar I, Muller RU, Straka E, Su L, Burki EA, et al: A SNP in a
let-7 microRNA complementary site in the KRAS 3′ untranslated
region increases non-small cell lung cancer risk. Cancer Res.
68:8535–8540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brendle A, Lei H, Brandt A, Johansson R,
Enquist K, Henriksson R, Hemminki K, Lenner P and Försti A:
Polymorphisms in predicted microRNA-binding sites in integrin genes
and breast cancer: ITGB4 as prognostic marker. Carcinogenesis.
29:1394–1399. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin
Y, Wang E, Wu M and Shen SH: Aberrant allele frequencies of the
SNPs located in microRNA target sites are potentially associated
with human cancers. Nucleic Acids Res. 35:4535–4541. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi XL, Guo ZJ, Wang XL, Liu XL and Shi
GF: SET8 expression is associated with overall survival in gastric
cancer. Genet Mol Res. 14:15609–15615. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaneko S and Yoshimura T: Time trend
analysis of gastric cancer incidence in Japan by histological
types, 1975–1989. Br J Cancer. 84:400–405. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yi P, Lu W, Guo J, Liu Q, Chen Z, Han J
and Li L: Development of a PCR/ligase detection
reaction/nanogold-based universal array approach for the detection
of low-abundant DNA point mutations. Cell Biochem Biophys.
61:629–636. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y,
Gu J, Lin J, Habuchi T and Wu X: Single nucleotide polymorphisms of
microRNA machinery genes modify the risk of renal cell carcinoma.
Clin Cancer Res. 14:7956–7962. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L,
Zeng Y, Miao R, Jin G, Ma H, et al: Genetic variants of miRNA
sequences and non-small cell lung cancer survival. J Clin Invest.
118:2600–2608. 2008.PubMed/NCBI
|
|
21
|
Xie Y, Wang Y, Zhao Y and Guo Z:
Single-nucleotide polymorphisms of microRNA processing machinery
genes are associated with risk for gastric cancer. Onco Targets
Ther. 8:567–571. 2015.PubMed/NCBI
|
|
22
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang B, Liu C, Diao L, Wang C and Guo Z: A
polymorphism at the microRNA binding site in the 3′ untranslated
region of C14orf101 is associated with non-Hodgkin lymphoma overall
survival. Cancer Genet. 207:141–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
